Clinical-pharmacological and experimental investigations with Septrin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D002761:Cholangitis / Q000188:drug therapy; D002764:Cholecystitis / Q000188:drug therapy; D002908:Chronic Disease; D048909:Diabetes Complications; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000652:urine; D006801:Humans; D008826:Microbial Sensitivity Tests; D011704:Pyelonephritis / Q000188:drug therapy; D011743:Pyrimidines / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology* / Q000652:urine
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole